Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Leases (2022 - 2023)

Historic Leases for Cullinan Therapeutics (CGEM) over the last 2 years, with Q3 2023 value amounting to $2.9 million.

  • Cullinan Therapeutics' Leases fell 3494.22% to $2.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.9 million, marking a year-over-year decrease of 3494.22%. This contributed to the annual value of $4.1 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Leases is $2.9 million, which was down 3494.22% from $3.5 million recorded in Q2 2023.
  • Cullinan Therapeutics' Leases' 5-year high stood at $4.5 million during Q3 2022, with a 5-year trough of $1.1 million in Q2 2022.